CAR-T cell researchers optimistic about future of treating blood cancers
Survival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some blood cancers.
Sep 15, 2023
0
40
Chemically-Induced Disorders: News and Research on Neurotoxicity Syndromes
MeSH tree: C25.723.705
New technique helps CAR T therapies fight cancer cells while minimizing severe side effects
In recent years, cancer researchers have hailed the arrival of chimeric antigen receptor T cell (CAR T) therapy, which has delivered promising results, transforming the fight against various forms of cancer. The process involves ...
Sep 13, 2023
0
54
Breakthrough CAR-T cancer treatments are boosting patients' quality of life
A therapy that bolsters the immune system may not only help certain cancer patients live longer, but better, a new study finds.
Apr 5, 2023
0
55
Calcium: A key player for a promising and safe brain treatment?
A promising therapy for a range of brain diseases involves antisense oligonucleotides (ASOs)—specialized molecules that can modulate RNA and alter protein production—directly injected into the cerebrospinal fluid, in the ...
Mar 13, 2023
0
575
Antipsychotic withdrawal—an unrecognized and misdiagnosed problem
It's not withdrawal, it's a relapse of your illness. This is what many people trying to stop their antipsychotic drugs are told when seeking support to get off the medication.
Jan 9, 2023
0
154
Simple blood test predicts neurotoxic complications of CAR-T cell therapy
Cell-based immunotherapy called CAR-T cell therapy has revolutionized the treatment of several cancers. The treatment uses genetically modified T cells to target and attack certain types of leukemia and lymphoma. While it ...
Sep 1, 2022
0
63
